Covid-19 vaccine: Covaxin submit data from early-to-middle stage trials to seek emergency use nod from regulators

Covid-19 vaccine: Covaxin submit data from early-to-middle stage trials to seek emergency use nod from regulators

Bharat Biotech becomes the third company to seek emergency use authorization for its vaccine after Pfizer nad Pune-based Serum Institute of India.
Check the source here –Source, Financial Express.
Change Language